Metabolic Cross Talk in the Tumor Microenvironment
Chinmay Das1, Somya Ranjan Dash2, Biswajit Das3
1School of Biotechnology, Kalinga Institute of Industrial Technology Deemed to be University, Bhubaneswar, Odisha, India.
Abstract:
The tumor microenvironment (TME) is a dynamic network of diverse cellular and noncellular components that interact with malignant cells to influence cancer progression, immune evasion, metastasis, and the development of therapeutic resistance. The major constituents of the TME include malignant cells, immune cells, stromal cells, endothelial cells (ECs), pericytes, adipocytes, nerve cells, and the extracellular matrix (ECM). Findings revealed that a dynamic metabolic crosstalk occurs continuously within the tumor niche, leading to metabolic rewiring in the tumor resident cells that supports cancer progression under nutrient deprivation, hypoxia, and acidosis conditions in TME. This chapter provides a comprehensive overview of various types of metabolic interactions between malignant cells and the diverse cellular components of the TME, including autocrine, paracrine, juxtacrine, and endocrine-like communication, and highlights the role of key metabolites involved in this type of communication. Thus, the interplay between malignant and tumor-resident cells emphasizes their metabolic interactions that promote drug resistance. Additionally, the chapter explores the molecular mechanisms and signaling pathways triggered by this exchange of metabolites. The chapter also explores the molecular mechanisms and signaling pathways triggered by metabolite exchange and clarifies how dysregulated metabolic reprogramming contributes to cancer progression and drug resistance. Therefore, understanding these complex metabolic interactions within the tumor niche provides critical insights for developing novel therapeutic approaches that target the metabolic vulnerabilities of the malignant cells.
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

